Company: ATRA
Filing Date: 2025-03-07
Form Type: 8-K
Source: 0000950170-25-035482
Chunk: 0

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On March 7, 2025, the Company announced certain financial results for the fourth quarter and year ended December 31, 2024. A copy of the Company’s press release, titled “ Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress” is furnished as Exhibit 99.1 hereto.

The information set forth in this Item 2.02 and in the press release included as Exhibit 99.1 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any filing with the U. S. Securities and Exchange Commission, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.